Rapid development of seizures and PRES in a COVID-19 patient.

ABSTRACT: Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease.

SUBMITTER: Santos de Lima F 

PROVIDER: S-EPMC7931684 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature